Federation Des Caisses Desjardins Du Quebec Hepion Pharmaceuticals, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2024
SELL
$0.53 - $19.38 $1,855 - $67,830
-3,500 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$0.93 - $1.29 $3,255 - $4,515
3,500 New
3,500 $4.52 Million
Q2 2021

Aug 30, 2024
BUY
$1.56 - $2.26 $5,460 - $7,909
3,500 New
3,500 $6.93 Million
Q4 2020

Aug 30, 2024
BUY
$1.58 - $3.64 $5,530 - $12,740
3,500 New
3,500 $7.67 Million

About Hepion Pharmaceuticals, Inc.

HEPA Quotes by TradingView
  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $51.8M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email